1. Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
    Junlong Wu et al, 2017, Sci Rep CrossRef
  2. MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway.
    Yun-Tan Qiu et al, 2017, Oncol Rep CrossRef
  3. Tumor cell-associated immune checkpoint molecules – Drivers of malignancy and stemness
    Fabrizio Marcucci et al, 2017, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
  4. The tumor microenvironment: thousand obstacles for effector T cells
    Chiara Massa et al, 2017, Cellular Immunology CrossRef
  5. PI3K/Akt signaling is involved in the pathogenesis of bleomycin-induced pulmonary fibrosis via regulation of epithelial-mesenchymal transition
    Xiao-Ling Zhang et al, 2016 CrossRef
  6. Aberrant methylation of EYA4 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma
    Mei Luo et al, 2018, Cancer Sci CrossRef
  7. The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System
    Elisabetta Romeo et al, 2019, Cells CrossRef
  8. Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1
    Irma Herrera-Camacho et al, 2019, Expert Opinion on Therapeutic Patents CrossRef
  9. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Jiawen Xu et al, 2017, Biomed Pharmacother CrossRef
  10. IL-6 promotes metastasis of non-small-cell lung cancer by up-regulating TIM-4 via NF-κB.
    Wen Liu et al, 2020, Cell Prolif CrossRef
  11. TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition

    Yangyang Xiao et al, 2020, OTT CrossRef
  12. null
    Yaping Zhang et al, 2020 CrossRef
  13. Significance of TIM-3 Expression in Resected Esophageal Squamous Cell Carcinoma
    Yuhuan Zhao et al, 2020, The Annals of Thoracic Surgery CrossRef
  14. Down-regulation of long non-coding RNA ESCCAL_1 inhibits tumor growth of esophageal squamous cell carcinoma in a xenograft mouse model
    Yuanbo Cui et al, 2018, Oncotarget CrossRef
  15. Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
    Wentao Kuai et al, 2020, BioMed Research International CrossRef
  16. Prognostic and clinicopathological value of high expression of TIM ‐3 in different cancer types: A meta‐analysis
    Wenbo Xu et al, 2020, Precision Medical Sciences CrossRef
  17. Prognostic Values of TIM-3 Expression in Patients With Solid Tumors: A Meta-Analysis and Database Evaluation
    Shuang Qin et al, 2020, Front. Oncol. CrossRef
  18. Varied functions of immune checkpoints during cancer metastasis
    Ali Safarzadeh et al, 2020, Cancer Immunol Immunother CrossRef
  19. Acute Conditioning of Antigen-Expanded CD8+ T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge
    Pavla Taborska et al, 2020, Cancers CrossRef
  20. TIM ‐3 polymorphism is involved in the progression of esophageal squamous cell carcinoma by regulating gene expression
    Sai‐Jin Cui et al, 2021, Environ Mol Mutagen CrossRef
  21. Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
    Fabrizio Marcucci et al, 2021, Cells CrossRef
  22. Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC
    Reihaneh Alsadat Mahmoudian et al, 2021, J Mol Histol CrossRef
  23. Delphinidin inhibits epidermal growth factor‐induced epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cells
    Won‐Chul Lim et al, 2019, J Cell Biochem CrossRef
  24. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
    Ding-Kang Wang et al, 2021, Front. Immunol. CrossRef
  25. The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma
    Jishuai Zhang et al, 2021, BioMed Research International CrossRef
  26. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
    Qian Luo et al, 2022, Front. Oncol. CrossRef
  27. Current and Future Immunotherapy-Based Treatments for Oesophageal Cancers
    Natalie To et al, 2022, Cancers CrossRef
  28. Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma
    Qianqian Zhang et al, 2022, Oncogene CrossRef
  29. The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation
    Xi-Yang Tang et al, 2022, Cancers CrossRef
  30. Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications
    Zhongquan Cheng et al, 2022, Eur J Nucl Med Mol Imaging CrossRef